This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment | MicrobiomeTrials
← Back to trials NCT07444567
Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment Recruiting PHASE3 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2026-07-24Est. Completion: 2029-12-27
Enrollment target: 230 participantsLocations Research Site, Aurora, Colorado, United States Research Site, Bethesda, Maryland, United States Research Site, Ann Arbor, Michigan, United States Research Site, Northfield, New Jersey, United States Research Site, The Bronx, New York, United States Research Site, Durham, North Carolina, United States Research Site, Cleveland, Ohio, United States Research Site, Salt Lake City, Utah, United States Research Site, Buenos Aires, Argentina Research Site, Florida, Argentina Research Site, Lobos, Argentina Research Site, Mar del Plata, Argentina Research Site, Mendoza, Argentina Research Site, Mendoza, Argentina Research Site, Rosario, Argentina Research Site, Rosario, Argentina Research Site, San Juan Bautista, Argentina Research Site, Innsbruck, Austria Research Site, Brussels, Belgium Research Site, Edegem, Belgium Other microbiome trials you might be interested in Asthma Asthma in Children Allergy Rhinitis, Allergic Atopic Dermatitis Allergen Immunotherapy
The summary is available at --\> https://www.finnatopy.fi/summary
Tampere, Finland Completed Dec 2032
Food Allergy in Children
The aim is to study whether a multiallergen oral immunotherapy (OIT) strategy with slow up-dosing and low treatment dose…
Multiple Locations Est. completion Dec 2032
Research Site, Calgary, Alberta, Canada
Research Site, Hamilton, Ontario, Canada
Research Site, Toronto, Ontario, Canada
Research Site, Toronto, Ontario, Canada
Research Site, Toronto, Ontario, Canada
Research Site, Bron, France
Research Site, Marseille, France
Research Site, Montpellier, France
Research Site, Nantes, France
Research Site, Paris, France
Research Site, Paris, France
Research Site, Pessac, France
Research Site, Suresnes, France
Research Site, Ahmedabad, India
Research Site, Ajmer, India
Research Site, Haifa, Israel
Research Site, Holon, Israel
Research Site, Petah Tikva, Israel
Research Site, Roma, Italy
Research Site, Rotterdam, Netherlands
Research Site, Chęciny, Poland
Research Site, Gdansk, Poland
Research Site, Lodz, Poland
Research Site, Lodz, Poland
Research Site, Incheon, South Korea
Research Site, Istanbul, Turkey (Türkiye)
Research Site, London, United Kingdom Asthma Acute COPD Exacerbation Acute
A Phase 2, open-label, single-arm trial to evaluate IV rademikibart as an add-on treatment for acute exacerbation in par…
Miami, United States Est. completion Dec 2026